This is significant because it offers a dual benefit for diabetic patients who are at high risk of kidney disease
Weight loss may continue steadily: Some people notice little difference in their progress after they switch, while others experience a brief adjustment period before seeing consistent results again
Until recently, the most effective new obesity medications, including semaglutide (Wegovy) and tirzepatide (Zepbound), were available only as injectables
This implies that it is going to burn fewer calories to defend itself
However, it is plausible that other bacterial populations are significantly changed upon VSL#3 administration, and further metagenomic studies will provide a comprehensive understanding of the microbiome changes elicited by VSL#3
J Ethnopharmacol 151(2):10051018 Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE (2014) Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases